Harbinger Health

Pioneering the detection of early cancer.

Cambridge, United States · Founded 2021 · $290.0M raised

Employees
51–200
Founded
2021
Business Model
B2B
Total Funding
$290.0M
Last Round
$100.0M Series CApr 2026
Rounds
3

About

Harbinger Health is a Cambridge, Massachusetts-based biotechnology company focused on advancing cancer detection through a biology-first approach. Founded in 2021 as a Flagship Pioneering company, Harbinger develops blood-based tests that combine developmental biology insights with AI and advanced analytics to detect cancer at its earliest biological signals. The company RESOLVE portfolio introduces a new category of diagnostics designed to address the critical gap between clinical suspicion of cancer and definitive diagnosis.

Summary

Harbinger Health is an Artificial Intelligence company based in Cambridge, United States, founded in 2021. It has raised $290.0M in total across 3 rounds, most recently a $100.0M Series C round in Apr 2026. Investors include Flagship Pioneering.

Tech & App Stack

3 technologies & apps tracked

Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.

Sign up to view the funding chart

Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

Series CSeries CApr 2026
$100.0M

Sign up to see all 3 rounds

Full funding history, per-round amounts, and investor participation.

Investors

Similar Companies